SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kadant Inc. – ‘10-Q’ for 7/2/22 – ‘EX-31.1’

On:  Wednesday, 8/10/22, at 2:14pm ET   ·   For:  7/2/22   ·   Accession #:  886346-22-125   ·   File #:  1-11406

Previous ‘10-Q’:  ‘10-Q’ on 5/11/22 for 4/2/22   ·   Next:  ‘10-Q’ on 11/9/22 for 10/1/22   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/10/22  Kadant Inc.                       10-Q        7/02/22   67:7.4M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Kai Form 10Q Q2 2022                                HTML   1.67M 
 2: EX-10.1     Kai Form 10Q Q2 2022 Exhibit 10.1                   HTML     57K 
 3: EX-31.1     Kai Form 10Q Q2 2022 Exhibit 31.1                   HTML     24K 
 4: EX-31.2     Kai Form 10Q Q2 2022 Exhibit 31.2                   HTML     24K 
 5: EX-32       Kai Form 10Q Q2 2022 Exhibit 32                     HTML     22K 
11: R1          Cover                                               HTML     73K 
12: R2          Condensed Consolidated Balance Sheet (Unaudited)    HTML    140K 
13: R3          Condensed Consolidated Balance Sheet (Unaudited)    HTML     41K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statement of Income          HTML    109K 
                (Unaudited)                                                      
15: R5          Condensed Consolidated Statement of Comprehensive   HTML     60K 
                Income (Unaudited)                                               
16: R6          Condensed Consolidated Statement of Comprehensive   HTML     25K 
                Income (Unaudited) (Parenthetical)                               
17: R7          Condensed Consolidated Statement of Cash Flows      HTML    116K 
                (Unaudited)                                                      
18: R8          Condensed Consolidated Statement of Stockholders'   HTML     90K 
                Equity (Unaudited)                                               
19: R9          Condensed Consolidated Statement of Stockholders'   HTML     22K 
                Equity (Unaudited) (Parenthetical)                               
20: R10         Nature of Operations and Summary of Significant     HTML    150K 
                Accounting Policies                                              
21: R11         Gain on Sale and Other Expense, Net                 HTML     24K 
22: R12         Earnings per Share                                  HTML     42K 
23: R13         Provision for Income Taxes                          HTML     25K 
24: R14         Short- and Long-Term Obligations                    HTML     45K 
25: R15         Stock-Based Compensation                            HTML     25K 
26: R16         Accumulated Other Comprehensive Items               HTML     67K 
27: R17         Derivatives                                         HTML     63K 
28: R18         Fair Value Measurements and Fair Value of           HTML     75K 
                Financial Instruments                                            
29: R19         Business Segment Information                        HTML     83K 
30: R20         Commitments and Contingencies                       HTML     25K 
31: R21         Nature of Operations and Summary of Significant     HTML     66K 
                Accounting Policies (Policies)                                   
32: R22         Nature of Operations and Summary of Significant     HTML    161K 
                Accounting Policies (Tables)                                     
33: R23         Earnings per Share (Tables)                         HTML     41K 
34: R24         Short- and Long-Term Obligations (Tables)           HTML     32K 
35: R25         Accumulated Other Comprehensive Items (Tables)      HTML     68K 
36: R26         Derivatives (Tables)                                HTML     61K 
37: R27         Fair Value Measurements and Fair Value of           HTML     73K 
                Financial Instruments (Tables)                                   
38: R28         Business Segment Information (Tables)               HTML     76K 
39: R29         Nature of Operations and Summary of Significant     HTML     53K 
                Accounting Policies - Narrative (Details)                        
40: R30         Nature of Operations and Summary of Significant     HTML     44K 
                Accounting Policies - Supplemental Cash Flow                     
                Information (Details)                                            
41: R31         Nature of Operations and Summary of Significant     HTML     30K 
                Accounting Policies - Cash, Cash Equivalents, and                
                Restricted Cash (Details)                                        
42: R32         Nature of Operations and Summary of Significant     HTML     30K 
                Accounting Policies - Inventories (Details)                      
43: R33         Nature of Operations and Summary of Significant     HTML     50K 
                Accounting Policies - Goodwill (Details)                         
44: R34         Nature of Operations and Summary of Significant     HTML     29K 
                Accounting Policies - Warranty Obligations                       
                (Details)                                                        
45: R35         Nature of Operations and Summary of Significant     HTML     44K 
                Accounting Policies - Revenue Recognition Method                 
                and Disaggregation of Revenue by Product Type and                
                Geography (Details)                                              
46: R36         Nature of Operations and Summary of Significant     HTML     25K 
                Accounting Policies - Revenue from Contract with                 
                Customers (Details)                                              
47: R37         Gain on Sale and Other Expense, Net (Details)       HTML     44K 
48: R38         Earnings per Share - Basic and Diluted Earnings     HTML     54K 
                Per Share (Details)                                              
49: R39         Earnings per Share - Narrative (Details)            HTML     25K 
50: R40         Provision for Income Taxes (Details)                HTML     26K 
51: R41         Short- and Long-Term Obligations - Schedule of      HTML     39K 
                Short- and Long-Term Obligations (Details)                       
52: R42         Short- and Long-Term Obligations - Narrative        HTML     84K 
                (Details)                                                        
53: R43         Stock-Based Compensation (Details)                  HTML     41K 
54: R44         Accumulated Other Comprehensive Items - Components  HTML     60K 
                of AOCI (Details)                                                
55: R45         Accumulated Other Comprehensive Items -             HTML     63K 
                Reclassification Out of AOCI (Details)                           
56: R46         Derivatives - Narrative (Details)                   HTML     38K 
57: R47         Derivatives - Fair Value of Derivative Instruments  HTML     46K 
                (Details)                                                        
58: R48         Derivatives - Activity in Accumulated Other         HTML     47K 
                Comprehensive Items (Oci) (Details)                              
59: R49         Fair Value Measurements and Fair Value of           HTML     54K 
                Financial Instruments - Fair Value of Assets and                 
                Liabilities Measured on a Recurring Basis                        
                (Details)                                                        
60: R50         Fair Value Measurements and Fair Value of           HTML     36K 
                Financial Instruments - Carrying Value and Fair                  
                Value of Debt Obligations (Details)                              
61: R51         Business Segment Information (Details)              HTML     94K 
62: R52         Commitments and Contingencies (Details)             HTML     23K 
65: XML         IDEA XML File -- Filing Summary                      XML    120K 
63: XML         XBRL Instance -- kai-20220702_htm                    XML   1.99M 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX    120K 
 7: EX-101.CAL  XBRL Calculations -- kai-20220702_cal                XML    169K 
 8: EX-101.DEF  XBRL Definitions -- kai-20220702_def                 XML    467K 
 9: EX-101.LAB  XBRL Labels -- kai-20220702_lab                      XML   1.31M 
10: EX-101.PRE  XBRL Presentations -- kai-20220702_pre               XML    787K 
 6: EX-101.SCH  XBRL Schema -- kai-20220702                          XSD    119K 
66: JSON        XBRL Instance as JSON Data -- MetaLinks              357±   537K 
67: ZIP         XBRL Zipped Folder -- 0000886346-22-000125-xbrl      Zip    363K 


‘EX-31.1’   —   Kai Form 10Q Q2 2022 Exhibit 31.1


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 31.1
CERTIFICATION

I, Jeffrey L. Powell, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q for the period ended July 2, 2022 of Kadant Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
  
/s/ Jeffrey L. Powell
 Jeffrey L. Powell
 President and Chief Executive Officer




Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/10/22None on these Dates
For Period end:7/2/22
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  Kadant Inc.                       10-K       12/30/23  112:14M
 2/28/23  Kadant Inc.                       10-K       12/31/22  107:16M
Top
Filing Submission 0000886346-22-000125   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 7:33:34.1pm ET